66th ASH Annual Meeting: Thromboinflammation of Cancer Associated Thrombosis

Symposia: Scientific Workshop on Interplay Between Coagulation and Malignancy Scientific Workshops

Room 24 (San Diego Convention Center)

Moderators:

Nicola Potere, MD, G. D'Annunzio University of Chieti-Pescara and Lalitha Nayak, MD, University Hospitals Cleveland Medical Center

Disclosures:

No relevant conflicts of interest to declare.

This session will focus on the inflammatory pathways involved in mediating hypercoagulable state and endothelial toxicity in cancer.

Moderator Introduction

Nicola Potere, MD

Department of Medicine and Ageing Sciences, G. D'Annunzio University of Chieti-Pescara, Chieti, Italy

PAR-1 and Doxorubicin Induced Cardiotoxicity

Steven Grover, PhD

University of North Carolina at Chapel Hill, Chapel Hill, NC

Circulating Tumor DNA and Thrombosis in Cancer

Ang Li, MD, MS

Baylor College of Medicine, Houston, TX

CD200R1 and IL-17 Axis in Cancer Associated Thrombosis

Marisa Brake, PhD

Beth Israel Deaconess Medical Center, Boston, MA

JAK-STAT Inhibition of Endothelial Activation

Joan D Beckman, MD, PhD

University of Minnesota, Minneapolis, MN

Thromboinflammation Markers in Myeloproliferative Neoplasms (MPNs)

Alexandre Guy, MD, PhD

Biology of Cardiovascular Diseases, University of Bordeaux, INSERM, UMR1034, Pessac, France; Bordeaux University Hospital, PESSAC, France; Bordeaux University Hospital, Laboratory of Hematology, Bordeaux, France

Hypercoagulability and Inflammatory Biomarkers Predict Disease Progression Non-Small Cell Lung Cancer Patients

Marina Marchetti, PhD

Department of Immunohematology and Transfusion Medicine, Papa Giovanni XXIII Hospital, Bergamo, Italy

Panel Discussion

See more of: Scientific Workshop on Interplay Between Coagulation and Malignancy
See more of: Scientific Workshops

<< Previous Session | Next Session >>